A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease
Authors:
- T J McElwainTMT J McElwain
- J ToyJTJ Toy
- E SmithESE Smith
- M J PeckhamMPM J Peckham
- D E AustinDAD E Austin
Open Access
- 1 August 1977
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 36 (2) , 276-280
Abstract
Seventy patients with Hodgkin's disease have been treated with a combination of chlorambucil, vinblastine, procarbazine and prednisolone (Ch1VPP). The complete remission rate of 75-7% compares well with that produced by other combinations. The combination is non-toxic, easily administered and can be given safely to outpatients. Its main advantage is that it is far less upsetting to patients than combinations containing nitrogen mustard.Keywords
This publication has 5 references indexed in Scilit:
- Combination chemotherapy in advanced and recurrent Hodgkin's disease.1973
- Report of the Committee on Hodgkin's Disease Staging Classification.1971
- Combination Chemotherapy in the Treatment of Advanced Hodgkin's DiseaseAnnals of Internal Medicine, 1970
- Combination Chemotherapy in Generalized Hodgkin's DiseaseBMJ, 1970
- Combined Vinblastine and Chlorambucil Therapy of Hodgkin's DiseaseAnnals of Internal Medicine, 1965